Drug
Aro Muc5ac
Aro Muc5ac: highest development phase Phase 1/2, developed by Arrowhead Pharmaceuticals. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1/2
- Developer
- Arrowhead Pharmaceuticals
Trials
| Drug | Phase | Indication |
|---|---|---|
| ARO-MUC5AC NCT05292950 | Phase 1/2 | Asthma |
Latest
No recent events.
Follow Aro Muc5ac on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.